SCHEMBL7981228

SCHEMBL7981228

Cc1cccc(C)c1Nc1nc2cccc([N+](=O)[O-])c2n2cncc12

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
LCK P06239 20/20 1.00
SRC P12931 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7970454 0.93 LCK (0.86) LCKSRC
SCHEMBL7983990 0.91 LCK (0.83) LCK
SCHEMBL7983509 0.88 LCK (0.77) LCK
SCHEMBL7969950 0.87 LCK (0.77) LCK
SCHEMBL7980776 0.87 LCK (0.77) LCKSRC
SCHEMBL7969975 0.87 LCK (0.77) LCK
SCHEMBL7979624 0.87 LCK (0.76) LCK
SCHEMBL7982922 0.86 LCK (0.75) LCK
SCHEMBL7979850 0.86 LCK (0.75) LCK
SCHEMBL7984181 0.86 LCK (0.75) LCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6235740-B1 AUTOIMMUNE DISEASES; ANTIPROLIFERATION AGENTS BRISTOL-MYERS SQUIBB CO. 2001-05-22 US claimed
WO-1999009845-A1 IMIDAZOQUINOXALINE PROTEIN TYROSINE KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 1999-03-04 WO claimed
US-6235740-B1 AUTOIMMUNE DISEASES; ANTIPROLIFERATION AGENTS BRISTOL-MYERS SQUIBB CO. 2001-05-22 US disclosed